A detailed history of Quarry LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Quarry LP holds 3,200 shares of AXSM stock, worth $279,200. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,200
Previous 1,800 77.78%
Holding current value
$279,200
Previous $144 Million 79.34%
% of portfolio
0.07%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$65.72 - $80.5 $92,008 - $112,700
1,400 Added 77.78%
3,200 $258 Million
Q1 2024

May 15, 2024

BUY
$69.39 - $97.64 $124,902 - $175,752
1,800 New
1,800 $144 Million
Q3 2023

Nov 14, 2023

BUY
$69.25 - $82.21 $120,841 - $143,456
1,745 New
1,745 $122 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.74B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.